BackDisruption of Cytoplasmic Membranes: Antimicrobial Drugs and Mechanisms
Study Guide - Smart Notes
Tailored notes based on your materials, expanded with key definitions, examples, and context.
Disruption of Cytoplasmic Membranes
Introduction
Some antimicrobial drugs act by disrupting the cytoplasmic membranes of target organisms. This mechanism is particularly important in the treatment of fungal and parasitic infections, as well as some bacterial diseases. The cytoplasmic membrane is essential for maintaining cell integrity, and its disruption leads to cell death.
Antibacterial Drugs Targeting Cytoplasmic Membranes
Polymyxins: These are antibacterial drugs that disrupt the cytoplasmic membrane of Gram-negative bacteria. Polymyxins act by binding to the membrane and causing leakage of cellular contents, ultimately leading to cell death. Polymyxin B is a common example, but its use is limited due to toxicity and is often reserved for drug-resistant infections.
Gram-positive vs. Gram-negative Bacteria: Polymyxins are more effective against Gram-negative bacteria because of differences in membrane structure.
Antifungal Drugs Targeting Cytoplasmic Membranes
Azoles: This class includes drugs such as fluconazole. Azoles inhibit the synthesis of ergosterol, a vital component of fungal cell membranes. Without ergosterol, the membrane becomes disrupted and the fungus cannot survive.
Allylamines: Examples include terbinafine. Allylamines also inhibit ergosterol synthesis but act at a different step in the pathway compared to azoles.
Polyenes: Drugs such as nystatin and amphotericin B bind directly to ergosterol in fungal membranes, forming pores that disrupt membrane integrity and cause cell death. Amphotericin B is especially important for treating systemic fungal infections.
Selective Toxicity: These drugs are generally less toxic to human cells because human cell membranes contain cholesterol instead of ergosterol.
Antiparasitic Drugs Targeting Cytoplasmic Membranes
Praziquantel and Ivermectin: These drugs alter the permeability of cell membranes in parasitic worms, leading to paralysis and death of the parasite.
Summary Table: Major Drugs Disrupting Cytoplasmic Membranes
Drug/Class | Target Organism | Mechanism of Action | Example(s) |
|---|---|---|---|
Polymyxins | Bacteria (Gram-negative) | Bind to membrane phospholipids, disrupt membrane integrity | Polymyxin B |
Azoles | Fungi | Inhibit ergosterol synthesis | Fluconazole |
Allylamines | Fungi | Inhibit ergosterol synthesis (different step than azoles) | Terbinafine |
Polyenes | Fungi | Bind to ergosterol, form pores in membrane | Nystatin, Amphotericin B |
Praziquantel, Ivermectin | Parasitic worms | Alter membrane permeability | Praziquantel, Ivermectin |
Key Terms and Definitions
Cytoplasmic membrane: The phospholipid bilayer that encloses the cytoplasm of a cell, controlling the movement of substances in and out.
Ergosterol: A sterol component of fungal cell membranes, analogous to cholesterol in animal cells.
Selective toxicity: The ability of a drug to target microbial cells without harming host cells.
Examples and Applications
Amphotericin B is used to treat life-threatening systemic fungal infections, such as cryptococcal meningitis.
Polymyxin B is used topically for skin infections caused by Gram-negative bacteria.
Praziquantel is used to treat schistosomiasis and other parasitic worm infections.